Buscar
Mostrando ítems 31-40 de 1634
Neuropsychology and neuropsychiatry of neurodegenerative disorders
(Frontiers Research Foundation, 2015)
Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications
(Faculdade de Medicina / USP, 2011)
'Alzheimer's disease is the most common cause of dementia and its prevalence is expected to increase in the coming years. Therefore, accurate diagnosis is crucial for patients, clinicians and researchers. Neuroimaging ...
The degradation of amyloid beta as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses
(Springer/Plenum Publishers, 2002-11)
The deposition of 4-kDa amyloid beta peptide in the brain is a prominent feature of several human diseases. Such process is heterogeneous in terms of causative factors, biochemical phenotype, localization and clinical ...
Free-floating adult human brain-derived slice cultures as a model to study the neuronal impact of Alzheimer's disease-associated A beta oligomers
(Elsevier B.V., 2018-09-01)
Background: Slice cultures have been prepared from several organs. With respect to the brain, advantages of slice cultures over dissociated cell cultures include maintenance of the cytoarchitecture and neuronal connectivity. ...
Factores de riesgo modificables que predisponen al desarrollo de la enfermedad de alzheimer.
(Machala : Universidad Técnica de Machala, 2019)
Alzheimer's disease is the most frequent form of dementia, it is a progressive neurological disease in which the brain gradually wears out. It is estimated that 46.8 million people live with dementia in the world in 2015, ...
Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease
(International Journal Of Nanomedicine, 2015)
Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease
(International Journal Of Nanomedicine, 2015)
Emerging roles for high-density lipoproteins in neurodegenerative disorders
(Blackwell Publishing Inc., 2019)